Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Ex-FDA chief Gottlieb’s quick move to pharma raises eyebrows

Will join Pfizer board

- PMLiVE

CHMP blocks UCB/Amgen’s Evenity approval for osteoporosis

Another obstacle for drug

- PMLiVE

Alexion’s Soliris adds new approval in rare disease NMOSD

First ever drug approved for rare autoimmune disease

- PMLiVE

Pharma reputation lags behind real value, study suggests

Wide 'opportunity gap' for industry

- PMLiVE

Ideas Foundation wins Creative Floor Awards Talent Fund

Another win for the charity

- PMLiVE

Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements

No new government funds committed to no-deal medicines plans

- PMLiVE

$450m diagnostics sale will fuel more Syncona biotech funding

Radiopharmaceuticals firm sold to Braco Imaging

- PMLiVE

FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps

Could add $1bn to revenues, say analysts

- PMLiVE

AZ’s Imfinzi joins immunotherapy drive in small cell lung cancer

Tecentriq the leader in setting

A new EU in the making, what lies ahead for pharma?

Big decisions on Europe's leaders and strategy await

Empowering the MS patient through shared decision making

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

Blue Latitude Health

- PMLiVE

What pharma marketers can learn from Disney

Why we need to continue to innovate, and surprise our audience

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links